Genetic Signatures (ASX:GSS) FCF Yield % : -11.59 (As of May. 22, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Genetic Signatures FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Genetic Signatures's Trailing 12-Month Free Cash Flow is A$-16.21 Mil, and Market Cap is A$139.89 Mil. Therefore, Genetic Signatures's FCF Yield % for today is -11.59%.

The historical rank and industry rank for Genetic Signatures's FCF Yield % or its related term are showing as below:

ASX:GSS' s FCF Yield % Range Over the Past 10 Years
Min: -33.32 Med: -6.21 Max: 9.21
Current: -11.59

During the past 9 years, the highest FCF Yield % of Genetic Signatures was 9.21%. The lowest was -33.32%. And the median was -6.21%.

ASX:GSS's FCF Yield % is ranked worse than
64.66% of 232 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.5 vs ASX:GSS: -11.59

Genetic Signatures's FCF Margin % for the quarter that ended in Dec. 2023 was -158.13%.

Genetic Signatures FCF Yield % Historical Data

The historical data trend for Genetic Signatures's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Signatures FCF Yield % Chart

Genetic Signatures Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Yield %

Get a 7-Day Free Trial

-2.05

-3.86

-0.50

4.10

-27.29

Genetic Signatures Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial													5.81	-0.75	-15.90	-27.92	-14.05

Competitive Comparison of Genetic Signatures's FCF Yield %

For the Diagnostics & Research subindustry, Genetic Signatures's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genetic Signatures's FCF Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Signatures's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Genetic Signatures's FCF Yield % falls into.

Genetic Signatures FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Genetic Signatures's FCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-20.545	/	75.288123582
	=	-27.29%

Genetic Signatures's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-5.699	*	2	/	81.120105
	=	-14.05%

Genetic Signatures FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Genetic Signatures FCF Yield % Related Terms

Thank you for viewing the detailed overview of Genetic Signatures's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Signatures (ASX:GSS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Signatures Ltd (ASX:GSS) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Eliza Street, Newtown, Sydney, NSW, AUS, 2042

Website

https://www.geneticsignatures.com

Genetic Signatures Ltd proprietary PCR solutions and automated workflows routinely screen for multiple infectious diseases in a single test. Rapid and accurate results facilitate improved patient management and healthcare outcomes. GSS continues to expand its global reach with direct representation in Australia, Europe, and the United States, and growing distribution partnerships. The company operates under one business segment which is the research and commercialisation of identifying individual genetic signatures to diagnose diseases and disabilities.